2024-04-03 |
2024-04-01 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
3 000
+0.1%
19,08
57 240
USD
|
3 000
+0.1%
|
19,08
|
57 240
USD
|
|
2024-03-26 |
2024-03-22 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
2 500
+0.0%
19,98
49 950
USD
|
2 500
+0.0%
|
19,98
|
49 950
USD
|
|
2024-03-22 |
2024-03-20 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
1 500
+0.0%
17,68
26 520
USD
|
1 500
+0.0%
|
17,68
|
26 520
USD
|
|
2024-03-07 |
2024-03-05 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
30 500
+0.6%
12,49
380 945
USD
|
30 500
+0.6%
|
12,49
|
380 945
USD
|
|
2024-03-06 |
2024-03-04 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
4 100
+0.1%
13,03
53 423
USD
|
4 100
+0.1%
|
13,03
|
53 423
USD
|
|
2024-02-21 |
2024-02-16 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
10 800
+0.2%
11,16
120 528
USD
|
10 800
+0.2%
|
11,16
|
120 528
USD
|
|
2024-02-20 |
2024-02-15 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
12 700
+0.2%
11,07
140 589
USD
|
12 700
+0.2%
|
11,07
|
140 589
USD
|
|
2023-11-14 |
2023-11-10 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
5 000
+0.1%
10,17
50 838
USD
|
5 000
+0.1%
|
10,17
|
50 838
USD
|
|
2023-11-07 |
2023-11-03 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
3 500
+0.1%
9,11
31 885
USD
|
3 500
+0.1%
|
9,11
|
31 885
USD
|
|
2023-10-31 |
2023-10-27 |
A
Achat
|
Thompson Jaye
VP Clinical Reg Affairs
Dirigeant
|
500
+0.2%
8,57
4 285
USD
|
500
+0.2%
|
8,57
|
4 285
USD
|
|
2023-10-30 |
2023-10-26 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
2 500
+0.0%
7,97
19 925
USD
|
2 500
+0.0%
|
7,97
|
19 925
USD
|
|
2023-10-27 |
2023-10-25 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
2 500
+0.0%
7,91
19 775
USD
|
2 500
+0.0%
|
7,91
|
19 775
USD
|
|
2023-10-12 |
2023-10-10 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
1 000
+0.0%
9,07
9 070
USD
|
1 000
+0.0%
|
9,07
|
9 070
USD
|
|
2023-10-05 |
2023-10-04 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
2 000
+0.0%
8,63
17 260
USD
|
2 000
+0.0%
|
8,63
|
17 260
USD
|
|
2023-09-28 |
2023-09-26 |
A
Achat
|
Thompson Jaye
VP Clinical Reg Affairs
Dirigeant
|
600
+0.2%
8,71
5 226
USD
|
600
+0.2%
|
8,71
|
5 226
USD
|
|
2023-09-21 |
2023-09-19 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
4 000
+0.1%
8,95
35 800
USD
|
4 000
+0.1%
|
8,95
|
35 800
USD
|
|
2023-09-13 |
2023-09-11 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
1 000
+0.0%
9,48
9 480
USD
|
1 000
+0.0%
|
9,48
|
9 480
USD
|
|
2023-08-24 |
2023-08-22 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
1 000
+0.0%
9,97
9 970
USD
|
1 000
+0.0%
|
9,97
|
9 970
USD
|
|
2023-08-08 |
2023-08-04 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
2 000
+0.0%
10,55
21 100
USD
|
2 000
+0.0%
|
10,55
|
21 100
USD
|
|
2023-07-25 |
2023-07-21 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
1 000
+0.0%
9,20
9 200
USD
|
1 000
+0.0%
|
9,20
|
9 200
USD
|
|
2023-07-17 |
2023-07-13 |
A
Achat
|
Thompson Jaye
VP Clinical Reg Affairs
Dirigeant
|
250
+0.1%
9,49
2 373
USD
|
250
+0.1%
|
9,49
|
2 373
USD
|
|
2023-05-18 |
2023-05-17 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
1 000
+0.0%
11,69
11 690
USD
|
1 000
+0.0%
|
11,69
|
11 690
USD
|
|
2023-05-02 |
2023-04-28 |
A
Achat
|
Thompson Jaye
VP Clinical Reg Affairs
Dirigeant
|
250
+0.1%
11,22
2 805
USD
|
250
+0.1%
|
11,22
|
2 805
USD
|
|
2023-04-21 |
2023-04-19 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
7 000
+0.1%
11,10
77 700
USD
|
7 000
+0.1%
|
11,10
|
77 700
USD
|
|
2023-04-20 |
2023-04-18 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
2 000
+0.0%
11,12
22 240
USD
|
2 000
+0.0%
|
11,12
|
22 240
USD
|
|
2023-04-12 |
2023-04-11 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
5 000
+0.1%
12,42
62 100
USD
|
5 000
+0.1%
|
12,42
|
62 100
USD
|
|
2023-04-12 |
2023-04-11 |
A
Achat
|
Thompson Jaye
VP Clinical Reg Affairs
Dirigeant
|
1 000
+0.4%
11,87
11 870
USD
|
1 000
+0.4%
|
11,87
|
11 870
USD
|
|
2023-03-16 |
2023-03-15 |
A
Achat
|
Thompson Jaye
VP Clinical Reg Affairs
Dirigeant
|
250
+0.1%
12,71
3 178
USD
|
250
+0.1%
|
12,71
|
3 178
USD
|
|
2023-03-13 |
2023-03-10 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
1 000
+0.0%
12,12
12 120
USD
|
1 000
+0.0%
|
12,12
|
12 120
USD
|
|
2023-02-28 |
2023-02-24 |
A
Achat
|
Thompson Jaye
VP Clinical Reg Affairs
Dirigeant
|
250
+0.1%
15,40
3 849
USD
|
250
+0.1%
|
15,40
|
3 849
USD
|
|
2023-02-22 |
2023-02-17 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
600
+0.0%
16,53
9 918
USD
|
600
+0.0%
|
16,53
|
9 918
USD
|
|
2023-02-14 |
2023-02-10 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
1 000
+0.0%
18,68
18 680
USD
|
1 000
+0.0%
|
18,68
|
18 680
USD
|
|
2023-02-07 |
2023-02-03 |
A
Achat
|
Thompson Jaye
VP Clinical Reg Affairs
Dirigeant
|
250
+0.1%
20,84
5 210
USD
|
250
+0.1%
|
20,84
|
5 210
USD
|
|
2023-01-31 |
2023-01-27 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
2 000
+0.1%
19,35
38 700
USD
|
2 000
+0.1%
|
19,35
|
38 700
USD
|
|
2023-01-30 |
2023-01-27 |
A
Achat
|
Thompson Jaye
VP Clinical Reg Affairs
Dirigeant
|
250
+0.1%
19,20
4 800
USD
|
250
+0.1%
|
19,20
|
4 800
USD
|
|
2023-01-24 |
2023-01-20 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
1 500
+0.1%
17,37
26 055
USD
|
1 500
+0.1%
|
17,37
|
26 055
USD
|
|
2023-01-17 |
2023-01-13 |
A
Achat
|
Thompson Jaye
VP Clinical Reg Affairs
Dirigeant
|
250
+0.1%
16,50
4 125
USD
|
250
+0.1%
|
16,50
|
4 125
USD
|
|
2023-01-10 |
2023-01-06 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
1 500
+0.1%
15,18
22 770
USD
|
1 500
+0.1%
|
15,18
|
22 770
USD
|
|
2023-01-03 |
2022-12-29 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
4 000
+0.1%
15,19
60 760
USD
|
4 000
+0.1%
|
15,19
|
60 760
USD
|
|
2022-12-20 |
2022-12-16 |
A
Achat
|
Thompson Jaye
VP Clinical Reg Affairs
Dirigeant
|
250
+0.1%
12,94
3 235
USD
|
250
+0.1%
|
12,94
|
3 235
USD
|
|
2022-12-20 |
2022-12-16 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
1 000
+0.0%
13,01
13 010
USD
|
1 000
+0.0%
|
13,01
|
13 010
USD
|
|
2022-12-13 |
2022-12-09 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
2 000
+0.1%
13,11
26 220
USD
|
2 000
+0.1%
|
13,11
|
26 220
USD
|
|
2022-12-06 |
2022-12-02 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
1 000
+0.0%
13,84
13 840
USD
|
1 000
+0.0%
|
13,84
|
13 840
USD
|
|
2022-12-06 |
2022-12-02 |
A
Achat
|
Thompson Jaye
VP Clinical Reg Affairs
Dirigeant
|
250
+0.1%
13,98
3 495
USD
|
250
+0.1%
|
13,98
|
3 495
USD
|
|
2022-11-04 |
2022-11-02 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
2 000
+0.1%
8,79
17 580
USD
|
2 000
+0.1%
|
8,79
|
17 580
USD
|
|
2022-10-17 |
2022-10-14 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
3 000
+0.1%
9,75
29 250
USD
|
3 000
+0.1%
|
9,75
|
29 250
USD
|
|
2022-10-11 |
2022-10-07 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
2 000
+0.1%
9,72
19 440
USD
|
2 000
+0.1%
|
9,72
|
19 440
USD
|
|
2022-10-04 |
2022-09-30 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
1 000
+0.0%
9,46
9 460
USD
|
1 000
+0.0%
|
9,46
|
9 460
USD
|
|
2022-10-03 |
2022-09-29 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
1 000
+0.0%
9,23
9 230
USD
|
1 000
+0.0%
|
9,23
|
9 230
USD
|
|
2022-06-27 |
2022-06-24 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
6 465
+0.2%
9,13
59 025
USD
|
6 465
+0.2%
|
9,13
|
59 025
USD
|
|
2022-06-27 |
2022-06-24 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
22 535
+0.8%
9,13
205 745
USD
|
22 535
+0.8%
|
9,13
|
205 745
USD
|
|
2022-06-17 |
2022-06-16 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
8 000
+0.3%
7,13
57 040
USD
|
8 000
+0.3%
|
7,13
|
57 040
USD
|
|
2022-06-15 |
2022-06-14 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
12 000
+0.5%
7,91
94 920
USD
|
12 000
+0.5%
|
7,91
|
94 920
USD
|
|
2022-06-13 |
2022-06-10 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
12 000
+0.5%
8,33
99 960
USD
|
12 000
+0.5%
|
8,33
|
99 960
USD
|
|
2022-06-10 |
2022-06-09 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
4 500
+0.4%
10,90
49 050
USD
|
4 500
+0.4%
|
10,90
|
49 050
USD
|
|
2022-06-08 |
2022-06-07 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
6 000
+0.5%
8,55
51 300
USD
|
6 000
+0.5%
|
8,55
|
51 300
USD
|
|
2022-06-06 |
2022-06-03 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
9 250
+0.8%
8,35
77 238
USD
|
9 250
+0.8%
|
8,35
|
77 238
USD
|
|
2022-06-03 |
2022-06-02 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
6 774
+0.6%
7,38
49 992
USD
|
6 774
+0.6%
|
7,38
|
49 992
USD
|
|
2022-04-26 |
2022-04-25 |
A
Achat
|
Daugherty Frank Joseph
Chief Medical Officer
Administrateur exécutif
|
1 000
+1.1%
16,25
16 250
USD
|
1 000
+1.1%
|
16,25
|
16 250
USD
|
|
2022-04-22 |
2022-04-21 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
6 000
+0.5%
16,09
96 540
USD
|
6 000
+0.5%
|
16,09
|
96 540
USD
|
|
2022-04-21 |
2022-04-19 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
6 000
+0.5%
16,74
100 440
USD
|
6 000
+0.5%
|
16,74
|
100 440
USD
|
|
2022-04-20 |
2022-04-19 |
A
Achat
|
Thompson Jaye
VP Clinical Reg Affairs
Dirigeant
|
500
+0.2%
16,74
8 370
USD
|
500
+0.2%
|
16,74
|
8 370
USD
|
|
2022-02-14 |
2022-02-11 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
5 500
+0.5%
19,80
108 900
USD
|
5 500
+0.5%
|
19,80
|
108 900
USD
|
|
2022-02-08 |
2022-02-04 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
5 000
+0.4%
19,59
97 950
USD
|
5 000
+0.4%
|
19,59
|
97 950
USD
|
|
2022-02-01 |
2022-01-31 |
A
Achat
|
Thompson Jaye
VP Clinical Reg Affairs
Dirigeant
|
500
+0.2%
18,47
9 235
USD
|
500
+0.2%
|
18,47
|
9 235
USD
|
|
2022-01-24 |
2022-01-21 |
A
Achat
|
Thompson Jaye
VP Clinical Reg Affairs
Dirigeant
|
500
+0.2%
16,33
8 165
USD
|
500
+0.2%
|
16,33
|
8 165
USD
|
|
2022-01-24 |
2022-01-21 |
A
Achat
|
Hallock Kenneth
Administrateur non-exécutif
|
300
+0.1%
16,32
4 896
USD
|
300
+0.1%
|
16,32
|
4 896
USD
|
|
2022-01-19 |
2022-01-18 |
A
Achat
|
Thompson Jaye
VP Clinical Reg. Affairs
Dirigeant
|
500
+0.2%
18,87
9 435
USD
|
500
+0.2%
|
18,87
|
9 435
USD
|
|
2022-01-18 |
2022-01-13 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
1 000
+0.1%
19,99
19 990
USD
|
1 000
+0.1%
|
19,99
|
19 990
USD
|
|
2022-01-14 |
2022-01-13 |
A
Achat
|
Daugherty Frank Joseph
Chief Medical Officer
Administrateur exécutif
|
1 000
+1.1%
19,99
19 990
USD
|
1 000
+1.1%
|
19,99
|
19 990
USD
|
|
2022-01-14 |
2022-01-13 |
A
Achat
|
Thompson Jaye
VP Clinical Reg. Affairs
Dirigeant
|
1 000
+0.4%
19,99
19 990
USD
|
1 000
+0.4%
|
19,99
|
19 990
USD
|
|
2022-01-04 |
2022-01-03 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
2 050
+0.2%
23,82
48 831
USD
|
2 050
+0.2%
|
23,82
|
48 831
USD
|
|
2021-12-16 |
2021-12-14 |
A
Achat
|
Daugherty Frank Joseph
Chief Medical Officer
Administrateur exécutif
|
1 111
+1.3%
26,99
29 983
USD
|
1 111
+1.3%
|
26,99
|
29 983
USD
|
|
2021-12-16 |
2021-12-14 |
A
Achat
|
Patel Snehal
CEO and CFO
Administrateur exécutif
Actionnaire important
|
1 840
+0.2%
27,17
49 992
USD
|
1 840
+0.2%
|
27,17
|
49 992
USD
|
|
2021-12-16 |
2021-12-14 |
A
Achat
|
McWilliams David
Administrateur non-exécutif
|
200
+0.0%
27,56
5 512
USD
|
200
+0.0%
|
27,56
|
5 512
USD
|
|